Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Role of Lipids in Retinal Vascular and Macular Disorders.

Prakash G, Agrawal R, Natung T.

Indian J Clin Biochem. 2017 Mar;32(1):3-8. doi: 10.1007/s12291-016-0560-2. Review.

PMID:
28149006
2.

Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.

Pennington KL, DeAngelis MM.

Eye Vis (Lond). 2016 Dec 22;3:34. doi: 10.1186/s40662-016-0063-5. Review.

3.

Intake of dietary salt and drinking water: Implications for the development of age-related macular degeneration.

Bringmann A, Hollborn M, Kohen L, Wiedemann P.

Mol Vis. 2016 Dec 22;22:1437-1454.

4.

Features of Age-Related Macular Degeneration in the General Adults and Their Dependency on Age, Sex, and Smoking: Results from the German KORA Study.

Brandl C, Breinlich V, Stark KJ, Enzinger S, Aßenmacher M, Olden M, Grassmann F, Graw J, Heier M, Peters A, Helbig H, Küchenhoff H, Weber BH, Heid IM.

PLoS One. 2016 Nov 28;11(11):e0167181. doi: 10.1371/journal.pone.0167181.

5.

Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related Macular Degeneration.

Handa JT, Cano M, Wang L, Datta S, Liu T.

Biochim Biophys Acta. 2017 Apr;1862(4):430-440. doi: 10.1016/j.bbalip.2016.07.013. Review.

PMID:
27480216
6.

Osmotic Induction of Angiogenic Growth Factor Expression in Human Retinal Pigment Epithelial Cells.

Veltmann M, Hollborn M, Reichenbach A, Wiedemann P, Kohen L, Bringmann A.

PLoS One. 2016 Jan 22;11(1):e0147312. doi: 10.1371/journal.pone.0147312.

7.

The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.

Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Cukras C, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study 2 Research Group..

Ophthalmology. 2015 Dec;122(12):2490-6. doi: 10.1016/j.ophtha.2015.08.028.

8.

Regulation of the hyperosmotic induction of aquaporin 5 and VEGF in retinal pigment epithelial cells: involvement of NFAT5.

Hollborn M, Vogler S, Reichenbach A, Wiedemann P, Bringmann A, Kohen L.

Mol Vis. 2015 Apr 9;21:360-77.

9.

Cholesterol-mediated activation of acid sphingomyelinase disrupts autophagy in the retinal pigment epithelium.

Toops KA, Tan LX, Jiang Z, Radu RA, Lakkaraju A.

Mol Biol Cell. 2015 Jan 1;26(1):1-14. doi: 10.1091/mbc.E14-05-1028.

10.

Lipids, lipid genes, and incident age-related macular degeneration: the three continent age-related macular degeneration consortium.

Klein R, Myers CE, Buitendijk GH, Rochtchina E, Gao X, de Jong PT, Sivakumaran TA, Burlutsky G, McKean-Cowdin R, Hofman A, Iyengar SK, Lee KE, Stricker BH, Vingerling JR, Mitchell P, Klein BE, Klaver CC, Wang JJ.

Am J Ophthalmol. 2014 Sep;158(3):513-24.e3. doi: 10.1016/j.ajo.2014.05.027. Review.

11.

Vasodilators, blood pressure-lowering medications, and age-related macular degeneration: the Beaver Dam Eye Study.

Klein R, Myers CE, Klein BE.

Ophthalmology. 2014 Aug;121(8):1604-11. doi: 10.1016/j.ophtha.2014.03.005. Erratum in: Ophthalmology. 2016 Apr;123(4):923.

12.

Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.

Macedo AF, Taylor FC, Casas JP, Adler A, Prieto-Merino D, Ebrahim S.

BMC Med. 2014 Mar 22;12:51. doi: 10.1186/1741-7015-12-51. Review.

13.

Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium.

Klein R, Meuer SM, Myers CE, Buitendijk GH, Rochtchina E, Choudhury F, de Jong PT, McKean-Cowdin R, Iyengar SK, Gao X, Lee KE, Vingerling JR, Mitchell P, Klaver CC, Wang JJ, Klein BE.

Ophthalmic Epidemiol. 2014 Feb;21(1):14-23. doi: 10.3109/09286586.2013.867512. Erratum in: Ophthalmic Epidemiol. 2014 Jun;21(3):204-5.

14.

Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration.

Guymer RH, Baird PN, Varsamidis M, Busija L, Dimitrov PN, Aung KZ, Makeyeva GA, Richardson AJ, Lim L, Robman LD.

PLoS One. 2013 Dec 31;8(12):e83759. doi: 10.1371/journal.pone.0083759.

15.

Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study.

Merle BM, Maubaret C, Korobelnik JF, Delyfer MN, Rougier MB, Lambert JC, Amouyel P, Malet F, Le Goff M, Dartigues JF, Barberger-Gateau P, Delcourt C.

PLoS One. 2013 Nov 6;8(11):e79848. doi: 10.1371/journal.pone.0079848.

16.

Aspirin use and risk of age-related macular degeneration: a meta-analysis.

Zhu W, Wu Y, Xu D, Li YH, Jun B, Zhang XL, Wang F, Yu J.

PLoS One. 2013;8(3):e58821. doi: 10.1371/journal.pone.0058821.

17.

Lipids, lipoproteins, and age-related macular degeneration.

Ebrahimi KB, Handa JT.

J Lipids. 2011;2011:802059. doi: 10.1155/2011/802059.

18.

Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).

Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, Tan PL, Oh EC, Merriam JE, Souied E, Bernstein PS, Li B, Frederick JM, Zhang K, Brantley MA Jr, Lee AY, Zack DJ, Campochiaro B, Campochiaro P, Ripke S, Smith RT, Barile GR, Katsanis N, Allikmets R, Daly MJ, Seddon JM.

Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7395-400. doi: 10.1073/pnas.0912019107.

19.

Risk factors for age-related maculopathy.

Connell PP, Keane PA, O'Neill EC, Altaie RW, Loane E, Neelam K, Nolan JM, Beatty S.

J Ophthalmol. 2009;2009:360764. doi: 10.1155/2009/360764.

20.

Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.

Maguire MG, Ying GS, McCannel CA, Liu C, Dai Y; Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group..

Ophthalmology. 2009 Dec;116(12):2381-5. doi: 10.1016/j.ophtha.2009.06.055.

Supplemental Content

Support Center